Archived Newsletters
-
02.21.24 -- What Does The Catalent Acquisition By Novo Holdings Mean For The Biopharma Industry?
2/21/2024
02/21/24 Outsourced Pharma Newsletter
-
02.20.24 -- What To Consider When Selecting A Contract Packaging Partner
2/20/2024
02/20/24 Outsourced Pharma Newsletter
-
02.20.24 -- A Future Renaissance At Catalent? Employees Think So
2/20/2024
02/20/24 Outsourced Pharma Newsletter
-
02.19.24 -- Partners To Support Your Biologic API & Drug Product Projects
2/19/2024
02/19/24 Outsourced Pharma Newsletter
-
02.19.24 -- What Does The Catalent Acquisition By Novo Holdings Mean For The Biopharma Industry?
2/19/2024
02/19/24 Outsourced Pharma Newsletter
-
02.16.24 -- Have Questions About Your Small Molecule API And Drug Product Projects?
2/16/2024
02/16/24 Outsourced Pharma Newsletter
-
02.16.24 -- Novo Holdings Clarifies, But Competitors Circling Catalent
2/16/2024
02/16/24 Outsourced Pharma Newsletter
-
02.15.24 -- Prioritize Your Finished Goods Experience To Advance Medicines To Patients
2/15/2024
02/15/24 Outsourced Pharma Newsletter
-
02.15.24 -- Novo Holdings Clarifies, But Competitors Circling Catalent
2/15/2024
02/15/24 Outsourced Pharma Newsletter
-
02.14.24 -- Partners Prepared For Your Aseptic Fill/Finish Needs
2/14/2024
02/14/24 Outsourced Pharma Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more